Skip to main content
Erschienen in: Diabetologia 12/2009

01.12.2009 | Commentary

Cognitive decline associated with dementia and type 2 diabetes: the interplay of risk factors

verfasst von: C. Messier, M. Gagnon

Erschienen in: Diabetologia | Ausgabe 12/2009

Einloggen, um Zugang zu erhalten

Excerpt

The possible association between type 2 diabetes and dementia, Alzheimer’s disease in particular, has been shrouded in confusion for some time, with some researchers noting that Alzheimer’s patients are rarely diabetic [1] but others suggesting diabetes to be a major risk factor for the disease [2]. Since an earlier review of the evidence [3], a number of things have become clearer. First, histopathological examinations of the brains of type 1 and type 2 diabetic patients have demonstrated that diabetes as such does not produce the amyloid plaques and neurofibrillary tangles considered hallmarks of Alzheimer’s disease [4]—a finding supported by a recent extensive post-mortem examination [5]. Second, research has shown that, in non-demented patients with type 2 diabetes, cognitive deficits are relatively mild before the age of 70 years, although they increase in frequency and severity thereafter [6]. Finally, people with type 2 diabetes who maintain less than optimal glycaemic control (i.e. with many occurrences of high blood glucose levels) are more likely to start manifesting cognitive deficits. Interestingly, improving glycaemic control in this population can reduce these cognitive deficits [7], suggesting that cognitive deficits might not be permanent in patients in whom presentation is early. …
Literatur
1.
Zurück zum Zitat Nielson KA, Nolan JH, Berchtold NC, Sandman CA, Mulnard RA, Cotman CW (1996) Apolipoprotein-E genotyping of diabetic dementia patients: is diabetes rare in Alzheimer's disease? [see comments]. J Am Geriatr Soc 44:897–904PubMed Nielson KA, Nolan JH, Berchtold NC, Sandman CA, Mulnard RA, Cotman CW (1996) Apolipoprotein-E genotyping of diabetic dementia patients: is diabetes rare in Alzheimer's disease? [see comments]. J Am Geriatr Soc 44:897–904PubMed
2.
Zurück zum Zitat Messier C (2003) Diabetes, Alzheimer’s disease and apolipoprotein genotype. Exp Gerontol 38:941–946CrossRefPubMed Messier C (2003) Diabetes, Alzheimer’s disease and apolipoprotein genotype. Exp Gerontol 38:941–946CrossRefPubMed
3.
Zurück zum Zitat Messier C, Gagnon M (1996) Glucose regulation and cognitive functions: relation to Alzheimer’s disease and diabetes. Behav Brain Res 75:1–11CrossRefPubMed Messier C, Gagnon M (1996) Glucose regulation and cognitive functions: relation to Alzheimer’s disease and diabetes. Behav Brain Res 75:1–11CrossRefPubMed
4.
Zurück zum Zitat Heitner J, Dickson D (1997) Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects. A retrospective postmortem immunocytochemical and histofluorescent study. Neurology 49:1306–1311PubMed Heitner J, Dickson D (1997) Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects. A retrospective postmortem immunocytochemical and histofluorescent study. Neurology 49:1306–1311PubMed
5.
Zurück zum Zitat Alafuzoff I, Aho L, Helisalmi S, Mannermaa A, Soininen H (2009) beta-Amyloid deposition in brains of subjects with diabetes. Neuropathol Appl Neurobiol 35:60–68CrossRefPubMed Alafuzoff I, Aho L, Helisalmi S, Mannermaa A, Soininen H (2009) beta-Amyloid deposition in brains of subjects with diabetes. Neuropathol Appl Neurobiol 35:60–68CrossRefPubMed
6.
Zurück zum Zitat Ryan CM, Geckle M (2000) Why is learning and memory dysfunction in type 2 diabetes limited to older adults? Diabetes Metab Res Rev 16:308–315CrossRefPubMed Ryan CM, Geckle M (2000) Why is learning and memory dysfunction in type 2 diabetes limited to older adults? Diabetes Metab Res Rev 16:308–315CrossRefPubMed
7.
Zurück zum Zitat Ryan CM, Freed MI, Rood JA, Cobitz AR, Waterhouse BR, Strachan MW (2006) Improving metabolic control leads to better working memory in adults with type 2 diabetes. Diabetes Care 29:345–351CrossRefPubMed Ryan CM, Freed MI, Rood JA, Cobitz AR, Waterhouse BR, Strachan MW (2006) Improving metabolic control leads to better working memory in adults with type 2 diabetes. Diabetes Care 29:345–351CrossRefPubMed
8.
Zurück zum Zitat van den Berg E, Kloppenborg RP, Kessels RP, Kappelle LJ, Biessels GJ (2009) Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: a systematic comparison of their impact on cognition. Biochim Biophys Acta 1792:470–481PubMed van den Berg E, Kloppenborg RP, Kessels RP, Kappelle LJ, Biessels GJ (2009) Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: a systematic comparison of their impact on cognition. Biochim Biophys Acta 1792:470–481PubMed
9.
Zurück zum Zitat Tiehuis AM, Mali WP, van Raamt AF et al (2009) Cognitive dysfunction and its clinical and radiological determinants in patients with symptomatic arterial disease and diabetes. J Neurol Sci 283:170–174CrossRefPubMed Tiehuis AM, Mali WP, van Raamt AF et al (2009) Cognitive dysfunction and its clinical and radiological determinants in patients with symptomatic arterial disease and diabetes. J Neurol Sci 283:170–174CrossRefPubMed
10.
Zurück zum Zitat Kim J, Basak JM, Holtzman DM (2009) The role of apolipoprotein E in Alzheimer’s disease. Neuron 63:287–303CrossRefPubMed Kim J, Basak JM, Holtzman DM (2009) The role of apolipoprotein E in Alzheimer’s disease. Neuron 63:287–303CrossRefPubMed
11.
Zurück zum Zitat Craft S, Teri L, Edland SD et al (1998) Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease. Neurology 51:149–153PubMed Craft S, Teri L, Edland SD et al (1998) Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease. Neurology 51:149–153PubMed
12.
Zurück zum Zitat Dore G, Elias M, Robbins M, Elias P, Nagy Z (2009) Presence of the APOE ε4 allele modifies the relationship between type 2 diabetes and cognitive performance: the Maine–Syracuse Study. Diabetologia. doi:10.1007/s00125-00009-01497-00122 PubMed Dore G, Elias M, Robbins M, Elias P, Nagy Z (2009) Presence of the APOE ε4 allele modifies the relationship between type 2 diabetes and cognitive performance: the Maine–Syracuse Study. Diabetologia. doi:10.​1007/​s00125-00009-01497-00122 PubMed
13.
Zurück zum Zitat Blair CK, Folsom AR, Knopman DS, Bray MS, Mosley TH, Boerwinkle E (2005) APOE genotype and cognitive decline in a middle-aged cohort. Neurology 64:268–276PubMed Blair CK, Folsom AR, Knopman DS, Bray MS, Mosley TH, Boerwinkle E (2005) APOE genotype and cognitive decline in a middle-aged cohort. Neurology 64:268–276PubMed
14.
Zurück zum Zitat Knopman DS, Mosley TH, Catellier DJ, Coker LH (2009) Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study. Alzheimers Dement 5:207–214CrossRefPubMed Knopman DS, Mosley TH, Catellier DJ, Coker LH (2009) Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study. Alzheimers Dement 5:207–214CrossRefPubMed
15.
Zurück zum Zitat Abi-Saab WM, Maggs DG, Jones T et al (2002) Striking differences in glucose and lactate levels between brain extracellular fluid and plasma in conscious human subjects: effects of hyperglycemia and hypoglycemia. J Cereb Blood Flow Metab 22:271–279CrossRefPubMed Abi-Saab WM, Maggs DG, Jones T et al (2002) Striking differences in glucose and lactate levels between brain extracellular fluid and plasma in conscious human subjects: effects of hyperglycemia and hypoglycemia. J Cereb Blood Flow Metab 22:271–279CrossRefPubMed
16.
Zurück zum Zitat Craft S, Watson GS (2004) Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurology 3:169–178CrossRefPubMed Craft S, Watson GS (2004) Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurology 3:169–178CrossRefPubMed
17.
Zurück zum Zitat Irie F, Fitzpatrick AL, Lopez OL et al (2008) Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study. Arch Neurol 65:89–93CrossRefPubMed Irie F, Fitzpatrick AL, Lopez OL et al (2008) Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study. Arch Neurol 65:89–93CrossRefPubMed
18.
Zurück zum Zitat Peila R, Rodriguez BL, Launer LJ (2002) Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies—The Honolulu–Asia Aging Study. Diabetes 51:1256–1262CrossRefPubMed Peila R, Rodriguez BL, Launer LJ (2002) Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies—The Honolulu–Asia Aging Study. Diabetes 51:1256–1262CrossRefPubMed
19.
Zurück zum Zitat Akomolafe A, Beiser A, Meigs JB et al (2006) Diabetes mellitus and risk of developing Alzheimer disease: results from the Framingham Study. Arch Neurol 63:1551–1555CrossRefPubMed Akomolafe A, Beiser A, Meigs JB et al (2006) Diabetes mellitus and risk of developing Alzheimer disease: results from the Framingham Study. Arch Neurol 63:1551–1555CrossRefPubMed
20.
Zurück zum Zitat MacKnight C, Rockwood K, Awalt E, McDowell I (2002) Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging. Dement Geriatr Cogn Disord 14:77–83CrossRefPubMed MacKnight C, Rockwood K, Awalt E, McDowell I (2002) Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging. Dement Geriatr Cogn Disord 14:77–83CrossRefPubMed
21.
Zurück zum Zitat Jellinger KA (2008) The pathology of "vascular dementia": a critical update. J Alzheimers Dis 14:107–123PubMed Jellinger KA (2008) The pathology of "vascular dementia": a critical update. J Alzheimers Dis 14:107–123PubMed
22.
Zurück zum Zitat Thompson CS, Hakim AM (2009) Living beyond our physiological means: small vessel disease of the brain is an expression of a systemic failure in arteriolar function: a unifying hypothesis. Stroke 40:e322–e330CrossRefPubMed Thompson CS, Hakim AM (2009) Living beyond our physiological means: small vessel disease of the brain is an expression of a systemic failure in arteriolar function: a unifying hypothesis. Stroke 40:e322–e330CrossRefPubMed
Metadaten
Titel
Cognitive decline associated with dementia and type 2 diabetes: the interplay of risk factors
verfasst von
C. Messier
M. Gagnon
Publikationsdatum
01.12.2009
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 12/2009
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-009-1533-2

Weitere Artikel der Ausgabe 12/2009

Diabetologia 12/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.